• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA与环状RNA在上皮性卵巢癌中的相互作用

Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.

作者信息

Schwarzenbach Heidi

机构信息

Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

出版信息

Noncoding RNA. 2024 Sep 30;10(5):51. doi: 10.3390/ncrna10050051.

DOI:10.3390/ncrna10050051
PMID:39452837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11510331/
Abstract

Epithelial ovarian cancer (EOC) with its high death incidence rate is generally detected at advanced stages. During its progression, EOC often develops peritoneal metastasis aggravating the outcomes of EOC patients. Studies on non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and circular RNAs (circRNAs), have analyzed the impact of miRNAs and circRNAs, along with their interaction among each other, on cancer cells. MiRNAs can act as oncogenes or tumor suppressors modulating post-transcriptional gene expression. There is accumulating evidence that circRNAs apply their stable, covalently closed, continuous circular structures to competitively inhibit miRNA function, and so act as competing endogenous RNAs (ceRNAs). This interplay between both ncRNAs participates in the malignity of a variety of cancer types, including EOC. In the current review, I describe the characteristics of miRNAs and circRNAs, and discuss their interplay with each other in the development, progression, and drug resistance of EOC. Sponging of miRNAs by circRNAs may be used as a biomarker and therapeutic target in EOC.

摘要

上皮性卵巢癌(EOC)死亡率高,通常在晚期才被发现。在其进展过程中,EOC常发生腹膜转移,加重患者预后。对非编码RNA(ncRNAs)的研究,如微小RNA(miRNAs)和环状RNA(circRNAs),分析了miRNAs和circRNAs及其相互作用对癌细胞的影响。miRNAs可作为癌基因或肿瘤抑制因子调节转录后基因表达。越来越多的证据表明,circRNAs利用其稳定的、共价闭合的连续环状结构竞争性抑制miRNA功能,从而作为竞争性内源RNA(ceRNAs)发挥作用。这两种ncRNAs之间的相互作用参与了包括EOC在内的多种癌症类型的恶性进展。在本综述中,我描述了miRNAs和circRNAs的特征,并讨论了它们在EOC的发生、发展和耐药性中的相互作用。circRNAs对miRNAs的海绵吸附作用可能作为EOC的生物标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11510331/0b065abd3dcd/ncrna-10-00051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11510331/c76c0d28ed09/ncrna-10-00051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11510331/0b065abd3dcd/ncrna-10-00051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11510331/c76c0d28ed09/ncrna-10-00051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11510331/0b065abd3dcd/ncrna-10-00051-g002.jpg

相似文献

1
Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.微小RNA与环状RNA在上皮性卵巢癌中的相互作用
Noncoding RNA. 2024 Sep 30;10(5):51. doi: 10.3390/ncrna10050051.
2
Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy.环状 RNA 与 miR-141 在癌症中的相互作用:从发病机制到诊断与治疗。
Int J Mol Sci. 2023 Jul 24;24(14):11861. doi: 10.3390/ijms241411861.
3
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites.Hsa_circ_0000497 和 hsa_circ_0000918 通过腹水促进卵巢癌细胞腹膜转移。
J Transl Med. 2022 May 10;20(1):201. doi: 10.1186/s12967-022-03404-9.
4
Review on circular RNAs and new insights into their roles in cancer.环状RNA综述及其在癌症中作用的新见解
Comput Struct Biotechnol J. 2021 Jan 22;19:910-928. doi: 10.1016/j.csbj.2021.01.018. eCollection 2021.
5
Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.长链非编码RNA与微小RNA在癌症中的相互作用
Methods Mol Biol. 2018;1819:75-92. doi: 10.1007/978-1-4939-8618-7_4.
6
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets.上皮性卵巢癌中的环状RNA:从生物标志物到治疗靶点
Cancers (Basel). 2022 Nov 21;14(22):5711. doi: 10.3390/cancers14225711.
7
Insights into the Evolving Roles of Circular RNAs in Cancer.环状RNA在癌症中不断演变的作用的见解
Cancers (Basel). 2021 Aug 20;13(16):4180. doi: 10.3390/cancers13164180.
8
Circular RNAs acting as ceRNAs mediated by miRNAs may be involved in the synthesis of soybean fatty acids.环状 RNA 通过 miRNA 作为 ceRNA 发挥作用,可能参与大豆脂肪酸的合成。
Funct Integr Genomics. 2021 Jul;21(3-4):435-450. doi: 10.1007/s10142-021-00791-y. Epub 2021 Jun 19.
9
Differentially expressed non-coding RNAs and their regulatory networks in liver cancer.肝癌中差异表达的非编码RNA及其调控网络
Heliyon. 2023 Aug 19;9(9):e19223. doi: 10.1016/j.heliyon.2023.e19223. eCollection 2023 Sep.
10
The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer.环状RNA和微小RNA在乳腺癌耐药性及靶向治疗反应中的作用
Cancer Drug Resist. 2024 Aug 20;7:30. doi: 10.20517/cdr.2024.62. eCollection 2024.

本文引用的文献

1
Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.环状 RNA 0070203 通过 miR-370-3p/TGFβR2 轴促进卵巢浆液性囊腺癌中的上皮-间质转化。
Recent Pat Anticancer Drug Discov. 2024;19(2):233-246. doi: 10.2174/1574892818666230328124804.
2
Analysis of Correlation between Rab1A Expression and its Prognosis in Cancers: a Meta-Analysis.Rab1A 表达与癌症预后相关性分析:荟萃分析。
Clin Lab. 2024 Jan 1;70(1). doi: 10.7754/Clin.Lab.2023.230660.
3
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
N6-甲基腺苷修饰的 circPLPP4 通过上调 PIK3R1 维持卵巢癌细胞对顺铂的耐药性。
Mol Cancer. 2024 Jan 6;23(1):5. doi: 10.1186/s12943-023-01917-5.
4
Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.在卵巢癌中,hsa_circ_0013561通过miR-23b-3p调控膜联蛋白A2(ANXA2),从而促进上皮-间质转化和肿瘤进展。
Cancer Gene Ther. 2024 Jan;31(1):108-118. doi: 10.1038/s41417-023-00686-z. Epub 2023 Dec 15.
5
CircCDK17 promotes the proliferation and metastasis of ovarian cancer cells by sponging miR-22-3p to regulate CD147 expression.环状 RNA CDK17 通过海绵吸附 miR-22-3p 调控 CD147 表达促进卵巢癌细胞的增殖和转移。
Carcinogenesis. 2024 Feb 12;45(1-2):83-94. doi: 10.1093/carcin/bgad079.
6
CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential.环状 RNA 在眼部新生血管疾病中的作用:基础机制与临床潜力。
Pharmacol Res. 2023 Nov;197:106946. doi: 10.1016/j.phrs.2023.106946. Epub 2023 Oct 4.
7
m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.m6A 修饰的 circASXL1 通过 miR-320d/RACGAP1 轴促进卵巢癌细胞的增殖和迁移。
Carcinogenesis. 2023 Dec 30;44(12):859-870. doi: 10.1093/carcin/bgad066.
8
m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.m6A 修饰的 circNFIX 通过海绵吸附 miR-647 激活 IL-6R/JAK1/STAT3 信号通路促进卵巢癌细胞进展和免疫逃逸。
Int Immunopharmacol. 2023 Nov;124(Pt A):110879. doi: 10.1016/j.intimp.2023.110879. Epub 2023 Sep 14.
9
NFIB facilitates replication licensing by acting as a genome organizer.NFIB 通过充当基因组组织者促进复制许可。
Nat Commun. 2023 Aug 21;14(1):5076. doi: 10.1038/s41467-023-40846-1.
10
AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis.AUF1 诱导的环状 RNA hsa_circ_0010467 通过 miR-637/LIF/STAT3 轴促进卵巢癌铂耐药性。
Cell Mol Life Sci. 2023 Aug 17;80(9):256. doi: 10.1007/s00018-023-04906-5.